Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis

Clinical Gastroenterology and Hepatology , 01/05/2011

New therapeutic strategies for gastroparesis include drugs that target the underlying defects, prokinetic agents such as 5–hydroxytryptamine agonists that do not appear to have cardiac or vascular effects, ghrelin agonists, approaches to pace the stomach, and stem cell therapies.

Print Article Summary Cat 2 CME Report